IDegLira: Redefining insulin optimisation using a single injection in patients with type 2 diabetes

• T2D typically requires treatment intensification to achieve blood glucose targets. • Many patients are not reaching these glycaemic targets. • GLP-1RAs combined with basal insulin can enable patients to achieve glycaemic control. • IDegLira is the first combination of a basal insulin and a GLP-1RA...

Description complète

Détails bibliographiques
Publié dans:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
Auteur principal: Hughes, Eugene (Auteur)
Format: Article en ligne
Langue:English
Publié: 2016
Accès à la collection:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
Sujets:Type 2 diabetes GLP-1 Intensification Insulin
Description matérielle:8
LEADER 01000caa a22002652 4500
001 ELV035237619
003 DE-627
005 20230624021425.0
007 cr uuu---uuuuu
008 180603s2016 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.pcd.2015.12.005  |2 doi 
028 5 2 |a GBVA2016009000002.pica 
035 |a (DE-627)ELV035237619 
035 |a (ELSEVIER)S1751-9918(15)00183-7 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
082 0 |a 610 
082 0 4 |a 610  |q DE-600 
082 0 4 |a 630  |q VZ 
082 0 4 |a 640  |q VZ 
082 0 4 |a 590  |q VZ 
082 0 4 |a 610  |q VZ 
082 0 4 |a 600  |q VZ 
084 |a 50.70  |2 bkl 
100 1 |a Hughes, Eugene  |e verfasserin  |4 aut 
245 1 0 |a IDegLira: Redefining insulin optimisation using a single injection in patients with type 2 diabetes 
264 1 |c 2016 
300 |a 8 
336 |a nicht spezifiziert  |b zzz  |2 rdacontent 
337 |a nicht spezifiziert  |b z  |2 rdamedia 
338 |a nicht spezifiziert  |b zu  |2 rdacarrier 
520 |a • T2D typically requires treatment intensification to achieve blood glucose targets. • Many patients are not reaching these glycaemic targets. • GLP-1RAs combined with basal insulin can enable patients to achieve glycaemic control. • IDegLira is the first combination of a basal insulin and a GLP-1RA in one pen. • The DUAL I and DUAL II studies show the effectiveness of this combination. 
650 7 |a Type 2 diabetes  |2 Elsevier 
650 7 |a GLP-1  |2 Elsevier 
650 7 |a Intensification  |2 Elsevier 
650 7 |a Insulin  |2 Elsevier 
773 0 8 |i Enthalten in  |n Elsevier  |a David, Lauren A. ELSEVIER  |t A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients  |d 2016  |g Amsterdam [u.a.]  |w (DE-627)ELV024210129 
773 1 8 |g volume:10  |g year:2016  |g number:3  |g pages:202-209  |g extent:8 
856 4 0 |u https://doi.org/10.1016/j.pcd.2015.12.005  |3 Volltext 
912 |a GBV_USEFLAG_U 
912 |a GBV_ELV 
912 |a SYSFLAG_U 
912 |a GBV_ILN_24 
912 |a GBV_ILN_40 
912 |a GBV_ILN_60 
912 |a GBV_ILN_72 
912 |a GBV_ILN_227 
912 |a GBV_ILN_350 
936 b k |a 50.70  |j Energie: Allgemeines  |q VZ 
951 |a AR 
952 |d 10  |j 2016  |e 3  |h 202-209  |g 8 
953 |2 045F  |a 610